Today, the rHEALTH ONE received a patent issuance from the United States Patent and Trademark Office. This patent issuance acknowledges the unique design of the biomedical instrument, including its small form factor, novel sample loading mechanism for microvolumes, and low power. The rHEALTH ONE utilizes the matchbox-sized cytometry module, microparticles, and small volume sample handling to allow a breadth of biomarker and cell analyses. The patent issuance further strengthens DMI’s intellectual property portfolio for its technology.
